Anorexia nervosa is a severe psychiatric illness with high mortality. Brain imaging research has indicated altered reward circuits in the disorder. Here we propose a disease model for anorexia nervosa, supported by recent studies, that integrates psychological and biological factors. In that model, we propose that there is a conflict between the conscious motivation to restrict food, and a body-homeostasis driven motivation to approach food in response to weight loss. These opposing motivations trigger anxiety, which maintains the vicious cycle of ongoing energy restriction and weight loss.
Introduction
At the 2018 annual meeting of the Society for the Study of Ingestive Behaviors in Bonita Springs, we presented recent data from our group on brain reward processing in anorexia nervosa (AN). Here we provide a background to those studies and present a model for the vicious cycle of food restriction and weight loss that occurs in AN despite being underweight.
A C C E P T E D M
A N U S C R I P T discrepancy between their conscious motivation for how much they want to eat -or rather restrict food intake -versus the body's need to stay at a healthy and sustainable body weight. Here we will summarize recent research from our group that is investigating motivational processes of food intake in AN together with other human and basic research to develop a psycho-biological model for how core AN behaviors develop and contribute to a continuous cycle of weight loss. Central to this model is the conflict between a conscious motivation to restrict eating and the unconscious messages from the body-homeostasis maintaining mechanisms including reward circuits and neuroendocrine systems to seek out food and to preserve a healthy body weight. This is a data-driven model that integrates empirically studied brain biology with measured behavior and weight gain observed in treatment.
AN is Associated with Altered Neuroendocrine and Brain Reward Circuit Function
During the course of AN, a multitude of changes happen in appetite regulating circuits. While the results are not all uniform, leptin as a marker of body fat is low, the appetite stimulating hormone ghrelin is elevated as are the stress markers cortisol and corticotropin releasing factor, and the level of the appetite reducing oxytocin is low in AN [13] . While those hormones and peptides that take part in regulating body homeostasis adapt to the acute nutritional state and typically normalize with weight recovery, they may have important roles in the modulation of the brain reward circuitry [14] .
The brain reward system is a well-studied circuitry that has been hypothesized to hold promise as a target for future treatment interventions in eating disorders including AN [14] . Especially important to eating and food reward is the taste pathway that projects inputs from the tongue taste receptors via the thalamus to the insula, which contains the primary taste cortex [15] . The reward system receives further input from frontal cortical regions about desires to consume foods, and it is connected with the hypothalamus to integrate signals from the body periphery such as blood sugar levels to regulate food intake and maintain energy homeostasis of the body [16] . The taste perception leads to learned associations between taste and subjective hedonic experiences to create an internal cognitive and emotional representation of food
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A C C E P T E D M A N U S C R I P T stimuli that gets activated when we see, smell or taste food [17] . Those associations provide dopamine mediated learning signals to higher-order brain regions to compare the current (food) experience with past experience and store new, or update previously stored, information on how much we value a particular food stimulus. This is to support the decision-making process for what type and amount of food we would like to eat in the future [18, 19] . The above described circuitry to motivate food intake is interrelated with the interoceptive signal of satiety, and a variety of gut hormones and neuropeptides together with specific brain regions contribute to this signal to regulate eating [20, 21] .
An increasing number of functional brain imaging studies have indicated altered activation in rewardprocessing brain regions in AN. It was hypothesized that such abnormalities together with anxious traits could contribute to AN-specific brain pathophysiology and drive extremes of food restriction [22] . Brain reward studies in AN have applied various paradigms using for instance food images to study emotional or hormonal response [23] .
Our lab has focused on brain dopamine function to study altered reward circuits in AN. The dopamine pathways are a neuromodulatory system that arises from cells in the midbrain [24] . These midbrain neurons release dopamine, which acts on cortical and subcortical dopamine receptors. Dopamine function contributes to the modulation of motor activity [25] , feeding behaviors [26] , and reinforcement and reward learning [27] . The dopamine system is particularly interesting to study as we know relatively more about the neuronal dynamics of its activation compared to other neurotransmitter systems and mathematical models have been developed to predict dopaminergic neuron response during presentation of rewarding or salient stimuli [28, 29] .
The dopamine system adapts in opposite directions to extremes of food intake [30] [31] [32] [33] . Animal models have shown enhanced neuronal dopamine activation following food restriction [34, 35] , which led to the hypothesis that brain dopamine circuits sensitize in AN in during food restriction and weight loss and are part of its specific pathophysiology [14, 22] . Food restriction sensitizes both dopamine D1 and D2/D3 receptors in animal studies, which is suggestive of being the underlying mechanism for enhanced dopamine neuron activation in response to weight loss [36, 37] .
A C C E P T E D M A N U S C R I P T Dopamine related brain function can be studied in humans indirectly using blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) and prediction error model tasks. The prediction error model is a model for how dopamine neurons respond to environmental stimuli and drive motivation to approach rewards and learn from rewarding or salient stimuli [41] . Dopamine neurons exhibit a phasic burst of activation in response to presentation of an unexpected rewarding stimulus, and a decrease in tonic dopamine neuron activity in response to unexpected omission of an expected reward stimulus [42] .
This model was first validated in rodents [43] and later adapted for human brain imaging [44, 45] . Those circuits are critically associated with providing signals regarding the presence and amplitude of rewards [16, 28] , and code the value of reward stimuli, including the metabolic value of food [46] [47] [48] [49] . In earlier studies, adults with AN showed elevated prediction error response (stronger positive response to unexpected receipt and stronger negative response to unexpected omission) to sucrose taste stimuli versus controls [50, 51] . This elevation in both directions was interpreted as a general sensitization of the dopamine neuronal response in AN. This was in contrast to obese individuals who showed lower prediction error response compared to controls, further supporting the adaptation of the dopamine system to the amount of food intake and consistent with basic science [32, 51] . A smaller elevation in prediction error response in long term recovered AN suggested a gradual normalization of brain response with illness recovery [52] . In summary, those studies suggested that dopamine-related reward processing is altered in AN and this led us to expand those studies to integrate behavior and treatment response with brain circuit activation.
A Model for Competing Motivations to Eat and Not to Eat in AN
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Recently we published a study in a large group of adolescents with AN (n=56), and an age-matched control group (n=52) [53] . In that study we applied a taste prediction error task as above. We also studied Lastly, prediction error response in AN was positively correlated with dynamic effective connectivity from ventral striatum to hypothalamus, an anxiety driven circuit that quickly inhibits food intake [54] . An additional smaller study in adolescent AN using a monetary reward prediction error task also showed elevated prediction error brain response together with negative correlation with BMI increase during treatment [55] . This suggested that enhanced prediction error response could be an illness state biomarker and independent from the stimulus type.
Based on those empirical data we propose a model for the continuous cycle of energy restriction in AN that integrates cognitive emotional factors such as drive for thinness, body dissatisfaction and fear of weight gain, with the body's adaptations to weight loss that include neuroendocrine factors as well as the changes in the brain dopamine system that occur with food restriction and weight loss (Figure 2. ).
Initiation of AN behavior:
AN is characterized by weight loss for various reasons. This can range from losing weight in the context of increased exercise to get fitter, to eating "healthier" (leaving out certain high
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A C C E P T E D M A N U S C R I P T calorie foods from the diet) as for instance often discussed in middle school health class, to overweight individuals who decidedly want to lose weight, to individuals who were maybe abused and alter their eating in that context, and variations in between. This "conscious motivation" to change eating or exercise behavior is then followed by weight loss. Weight loss is subsequently learned to be associated with the original goal of eating healthier, being fitter or thinner, and weight gain then may be perceived as a threat to that goal.
Underlying cognitive-emotional mechanisms: Not everyone who diets, or exercises more, develops AN. There are reports on specific underlying cognitive-emotional dynamics, for instance feeling in control, that drive food restriction in AN, but to what extent those have developed as part of the illness or have been there premorbidly is not known [56] . What is known is that individuals who develop AN tend to have anxious temperaments, biological traits such as high harm avoidance and perfectionism, which may facilitate development and maintenance of AN core behaviors [57] . Those traits that drive the desire to do things correctly are strong motivators of behavior in general, including eating disorder behaviors. Weight loss as an indicator of success then becomes a conditioned reward and cognitive reinforcer of the behavior. AN runs in families and we postulate a genetic predisposition for this transition from the initial motivation to change eating to core AN behaviors and excessive weight loss. We believe that brain changes occur that drive the extreme preoccupation with food and weight and shape. What the underlying biological mechanisms may be is unclear. Recent genetic research has shown an overlap between AN and obsessive compulsive disorder genes and the two disorders might share biological mechanisms that drive excessive behavior perpetuation [58] . Habit learning has also been hypothesized to be part of AN's pathophysiology and it is possible that high habit strength (the connection between stimulus and behavior response) together with heightened frontostriatal brain connectivity contribute to ongoing AN behaviors [59] [60] [61] .
Physiological response to weight loss: Animal models have shown that the body's normal response to
A C C E P T E D M A N U S C R I P T weight loss is an activation of the feeding system, including many adaptations of gut hormones and neuropeptides that signal to the hypothalamus the body's nutritional needs, as well as a sensitization of the dopamine system to support food approach [14, 16] . Food restriction is associated with increased brain cortisol, which affects dopamine release and postsynaptic dopamine D1 and D2 receptor function [37, 54, [62] [63] [64] . Those bodily feedback mechanisms (biological or "unconscious" motivation to stimulate weight gain) however are in stark contrast to the conscious motivation to restrict food intake and threaten the set goal of healthy eating, fitness, weight loss, etc. This creates an internal conflict and triggers the anxiety about losing control and giving in to the eating drive. Food avoidance and weight loss reduce those fears, but only briefly, until the fear of potential weight gain again dominates.
Chronic AN behavior:
The fear of weight gain supersedes the bodily mechanisms that drive food intake and further food restriction occurs. This positive feedback loop leads to ongoing food restriction, more weight loss, further stimulation of the biological feeding drive, followed by heightened anxiety etc. During the underweight state of AN measures for anxious traits such as harm avoidance are elevated and individuals with AN can often be observed getting more anxious with increasing weight loss, except for brief episodes of anxiety relief when meeting a weight loss goal or exercise [65, 66] . This supports that there may be a reinforcing mechanism between AN core behaviors and anxiety. AN is also associated with low gonadal hormones and basic science has suggested that females at low weight and low sex hormone levels show altered learning including reward learning [67] [68] [69] [70] . Low gonadal hormone levels in AN therefore may provide a neurobiological factor to impair behavior change and recovery, but the specific supporting studies in humans are still to be done.
Empirical data that support the model: Various psychosocial factors have been identified as triggers for
the initiation of AN, while family studies support a strong underlying biology that predisposes to developing the illness [71, 72] . Genetic factors that concern brain neurotransmitter function in the context of underweight or comorbid disorders such as obsessive compulsive disorder may play important roles but
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A C C E P T E D M
A N U S C R I P T need further study [58, 73] . The food restriction behaviors become self-reinforcing in the underweight state, facilitated by stress and anxiety, and over time worsening the clinical presentation as suggested in other research [74] [75] [76] [77] . Human studies have found that the frontostriatal connectivity, which has been associated with habit learning, was inversely correlated with actual food intake and thus could be a biological correlate for habit learning [78] . Animal models have supported repeatedly that weight loss is associated with physiological changes in the body and the brain reward circuitry, including dopamine release and receptor function, to drive food intake [36, 79, 80] . Our studies using the prediction error model support a similar pattern in humans with elevated dopamine-related reward system sensitivity associated with underweight [51, 53, 55] . The prediction error response was significantly positively correlated with anxiety (harm avoidance) in our AN group, and this anxiety correlated positively with core eating disorder thoughts and behaviors, drive for thinness and body dissatisfaction [53] . We also found evidence that dopamine responsiveness as reflected by the prediction error response may facilitate ongoing food restriction in AN when studying the dynamic connectivity between hypothalamus and ventral striatum. The hypothalamus integrates information about body homeostasis to drive food approach, but a fear mediated dopamine circuit from the ventral striatum to the hypothalamus has also been identified that inhibits food intake via dopamine D1 receptors [54, 81, 82] . We found that in the control group activity was directed from the hypothalamus to the ventral striatum, while in the AN group dynamic connectivity was directed from ventral striatum to the hypothalamus, and prediction error response was positively correlated with this connectivity in AN. We interpret this result that high anxiety triggers a ventral striatalhypothalamic circuitry that depends on dopamine D1 receptors and inhibits food intake [54, 82] . Those ventral striatal dopamine D1 receptors that take part in the prediction error response, are already sensitized due to weight loss and may be hyper responsive [37, 54, 83] . Clinically, prediction error activation correlated inversely with weight gain in treatment. This is in line with the positive correlation between prediction error response and effective connectivity strength of the ventral striatal-hypothalamic circuitry that controls food intake.
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Limitations to the model:
There is a host of endocrine factors that are altered in AN that could also interfere with normal eating and that are largely not integrated in the model due to lack of specific data [14] . In our study, anxiety was correlated with body dissatisfaction and drive for thinness, but we cannot exclude intrinsic abnormalities in body integration or interoception that may also worsen with weight loss and exacerbate the illness [84] . Alterations in brain structure and function may alter satiety processing in AN, which may be part of such a model and will need to be explored in future studies [85, 86] . The wellknown cognitive-emotional reinforcers that strengthen the cognitive aspect of desire to lose weight such as feedback from the environment, "you lost weight, you look good" were not assessed in our study. The so-called habit formation that may be part of this model for anorexia nervosa was not measured and including this concept remains conjectural at this point [87] . The model is based on correlations between brain function, clinical outcome and behavior. Whether mediator or moderator analyses can successfully be applied will require a larger data set and further exploration of the various variables. Comorbid depression and anxiety may also have vital parts in the pathophysiology of AN and those effects need further study.
Clinical Implications
The here presented model provides several clinical implications. For one, it provides a disease model that is helpful in helping individuals with AN or their caregivers better understand the illness. Second, the integration of brain biology that interferes with recovery increases empathy in both treatment providers and family or caregivers as it reduces blame and the idea that AN is simply a sociocultural disorder [88] .
Third, the model supports the important need to promote eating and weight gain to normalize the unconscious motivators for weight gain because normalization of eating will desensitize the feeding system. A study in AN after long term recovery indicated to a high degree normalization of prediction error response, while short term recovered individuals still showed widespread elevations of that signal [52, 55] . helpful when weight gain has started, and engaging intrinsic conscious motivation is crucial for sustained recovery [89] . Fifth, the model supports a biological treatment direction that targets the dopamine system.
The fear of weight gain can be so overwhelming that the use of logic and reasoning may be difficult to implement and altered brain dopamine function has been speculated in anxiety and altered insight in AN [90, 91] . Focus on management of temperamental traits such as high harm avoidance and punishment sensitivity may further aid in this process [92] . Elevated dopamine system sensitivity in AN might suggest applying a dopamine receptor blocking agent. However, many such drugs have been tried with poor success and this may be due to the brain expressing more receptors in response, which interferes with the desired effect of downregulating the system [12] . On the other hand, dopamine agonists could be helpful in supporting learning and behavior change, especially in females who are underweight and in a low estrogen state [93] . The dopamine D2 receptor also has effects on energy homeostasis, leptin signaling and body composition and there could be metabolic mechanisms that promote weight gain as well [94] [95] [96] [97] .
Thus, we have started to use the dopamine D2 receptor partial agonist aripiprazole with the rationale that it could support psychotherapy and weight gain. Recent data from our group indicate that aripiprazole may in fact be beneficial in weight gain during treatment of AN [98, 99] . However, aripiprazole also acts on serotonin and other neurotransmitter receptors. Whether aripiprazole's beneficial effects for AN treatment are specifically attributable to the drug's dopamine D2 receptor agonism is still unknown and requires further study and other neurotransmitters may also have key roles and need to be identified [93] .
Conclusion
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A C C E P T E D M A N U S C R I P T AN is a complex illness that is typically difficult to treat. Our limited understanding of AN's underlying neurobiology has prevented us from developing pharmacological interventions. Here we proposed a brainbased model of how the specific pathophysiology of AN develops and maintains the desire to lose weight despite being underweight. After deciding to change eating behavior or lose weight, perfectionism and high anxiety may mediate in individuals who are prone to develop AN, the transition to preoccupations with AN core behaviors such as drive for thinness and body dissatisfaction. The body's adaptations to weight loss that include sensitization of the dopamine system and activation of hypothalamic feeding circuits to stimulate eating, conflicts with the desire to lose weight. The fear of weight gain drives food restriction and leads to the ongoing self-reinforcing or positive feedback loop of emaciation, stimulation of feeding circuits, further fear of losing control over eating followed by starvation. The complexity of the illness and high relapse rate will require a combination of nutritional rehabilitation with more specific biological and psychotherapeutic interventions to improve treatment outcome.
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